Date Name Title Filing Type Shares Traded Price Total Held
May 01, 2012
Director, EVP CSO President Regeneron Re
Director, EVP CSO President Regeneron Re Form 4 Open market or private sale of non-derivative or derivative security 20,120 $134.54 845,986
Dec 14, 2010
VP Controller and Asst Treasur
VP Controller and Asst Treasur Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,180 -- 20,180
Dec 24, 2014
Ten Percent Owner
Ten Percent Owner Form 4 Open market or private purchase of non-derivative or derivative security 20,245 $399.74 22,859,144
Mar 28, 2014
Ten Percent Owner
Ten Percent Owner Form 4 Open market or private purchase of non-derivative or derivative security 20,264 $306.21 19,867,509
May 12, 2020
Director, President & CEO
Director, President & CEO Form 4 Open market or private sale of non-derivative or derivative security 20,267 $570.49 528,991
Jun 14, 2017
EVP Research and Development
EVP Research and Development Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 20,295 $21.25 44,245
Jun 14, 2017
EVP Research and Development
EVP Research and Development Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 20,295 -- --
Dec 18, 2009
SVP General Counsel and Secret
SVP General Counsel and Secret Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,295 -- 20,295
Apr 13, 2007
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 20,326 $24.60 98,379
Jul 03, 2014
Ten Percent Owner
Ten Percent Owner Form 4 Open market or private purchase of non-derivative or derivative security 20,376 $312.28 20,988,605

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.